Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nadege Pelletier currently holds 105,000 shares of Barinthus Biotherapeutics plc. (BRNS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nadege Pelletier has been a net neutral trader of BRNS stock. They have purchased $0 and sold $0 worth of shares.
Nadege Pelletier's most recent insider trade was on Jan 2, 2024, when they sold 105,000 shares at $0.00 per share.
Nadege Pelletier serves as Executive at Barinthus Biotherapeutics plc. (BRNS). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Nadege Pelletier holds the position of Executive at Barinthus Biotherapeutics plc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Nadege Pelletier has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Nadege Pelletier was on Jan 2, 2024, when they purchased $0 worth of BRNS shares. This transaction involved 105,000 shares at N/A per share.
Nadege Pelletier currently owns 105,000 shares of Barinthus Biotherapeutics plc. (BRNS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nadege Pelletier's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nadege Pelletier has 1 Form 4 filings on record as an insider at Barinthus Biotherapeutics plc..
Set alerts for Nadege Pelletier and 40,000+ other insiders.